1182 related articles for article (PubMed ID: 35196799)
21. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT
Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653
[TBL] [Abstract][Full Text] [Related]
22. Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters.
Briand F; Sencio V; Robil C; Heumel S; Deruyter L; Machelart A; Barthelemy J; Bogard G; Hoffmann E; Infanti F; Domenig O; Chabrat A; Richard V; Prévot V; Nogueiras R; Wolowczuk I; Pinet F; Sulpice T; Trottein F
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146875
[TBL] [Abstract][Full Text] [Related]
23. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
[TBL] [Abstract][Full Text] [Related]
24. Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic.
Blaurock C; Breithaupt A; Weber S; Wylezich C; Keller M; Mohl BP; Görlich D; Groschup MH; Sadeghi B; Höper D; Mettenleiter TC; Balkema-Buschmann A
Sci Rep; 2022 Sep; 12(1):15069. PubMed ID: 36064749
[TBL] [Abstract][Full Text] [Related]
25. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.
Brocato RL; Principe LM; Kim RK; Zeng X; Williams JA; Liu Y; Li R; Smith JM; Golden JW; Gangemi D; Youssef S; Wang Z; Glanville J; Hooper JW
J Virol; 2020 Oct; 94(22):. PubMed ID: 32900822
[TBL] [Abstract][Full Text] [Related]
26. Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.
Choudhary S; Kanevsky I; Yildiz S; Sellers RS; Swanson KA; Franks T; Rathnasinghe R; Munoz-Moreno R; Jangra S; Gonzalez O; Meade P; Coskran T; Qian J; Lanz TA; Johnson JG; Tierney CA; Smith JD; Tompkins K; Illenberger A; Corts P; Ciolino T; Dormitzer PR; Dick EJ; Shivanna V; Hall-Ursone S; Cole J; Kaushal D; Fontenot JA; Martinez-Romero C; McMahon M; Krammer F; Schotsaert M; García-Sastre A
Toxicol Pathol; 2022 Apr; 50(3):280-293. PubMed ID: 35128980
[TBL] [Abstract][Full Text] [Related]
27. Host Response of Syrian Hamster to SARS-CoV-2 Infection including Differences with Humans and between Sexes.
Castellan M; Zamperin G; Franzoni G; Foiani G; Zorzan M; Drzewnioková P; Mancin M; Brian I; Bortolami A; Pagliari M; Oggiano A; Vascellari M; Panzarin V; Crovella S; Monne I; Terregino C; De Benedictis P; Leopardi S
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851642
[TBL] [Abstract][Full Text] [Related]
28. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
[TBL] [Abstract][Full Text] [Related]
29. Persimmon-derived tannin has antiviral effects and reduces the severity of infection and transmission of SARS-CoV-2 in a Syrian hamster model.
Furukawa R; Kitabatake M; Ouji-Sageshima N; Suzuki Y; Nakano A; Matsumura Y; Nakano R; Kasahara K; Kubo K; Kayano SI; Yano H; Ito T
Sci Rep; 2021 Dec; 11(1):23695. PubMed ID: 34880383
[TBL] [Abstract][Full Text] [Related]
30. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.
Chiba S; Kiso M; Nakajima N; Iida S; Maemura T; Kuroda M; Sato Y; Ito M; Okuda M; Yamada S; Iwatsuki-Horimoto K; Watanabe T; Imai M; Armbrust T; Baric RS; Halfmann PJ; Suzuki T; Kawaoka Y
mBio; 2021 Feb; 13(1):e0304421. PubMed ID: 35100870
[TBL] [Abstract][Full Text] [Related]
31. Evidence for the spread of SARS-CoV-2 and olfactory cell lineage impairment in close-contact infection Syrian hamster models.
Ueha R; Ito T; Ueha S; Furukawa R; Kitabatake M; Ouji-Sageshima N; Uranaka T; Tanaka H; Nishijima H; Kondo K; Yamasoba T
Front Cell Infect Microbiol; 2022; 12():1019723. PubMed ID: 36339331
[TBL] [Abstract][Full Text] [Related]
32. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19.
Xue Y; Yang D; Vogel P; Stabenow J; Zalduondo L; Kong Y; Ravi Y; Sai-Sudhakar CB; Parvathareddy J; Hayes E; Taylor S; Fitzpatrick E; Jonsson CB
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891384
[TBL] [Abstract][Full Text] [Related]
33. Cellular tropism of SARS-CoV-2 in the respiratory tract of Syrian hamsters and B6.Cg-Tg(K18-ACE2)2Prlmn/J transgenic mice.
Yen HL; Valkenburg S; Sia SF; Choy KT; Peiris JSM; Wong KHM; Crossland N; Douam F; Nicholls JM
Vet Pathol; 2022 Jul; 59(4):639-647. PubMed ID: 34467820
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
[TBL] [Abstract][Full Text] [Related]
35. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY
Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458
[TBL] [Abstract][Full Text] [Related]
36. Severe Acute Respiratory Syndrome Coronavirus 2 Vasculopathy in a Syrian Golden Hamster Model.
Ball EE; Weiss CM; Liu H; Jackson K; Keel MK; Miller CJ; Van Rompay KKA; Coffey LL; Pesavento PA
Am J Pathol; 2023 Jun; 193(6):690-701. PubMed ID: 36906263
[TBL] [Abstract][Full Text] [Related]
37. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2.
Braxton AM; Creisher PS; Ruiz-Bedoya CA; Mulka KR; Dhakal S; Ordonez AA; Beck SE; Jain SK; Villano JS
Comp Med; 2021 Oct; 71(5):398-410. PubMed ID: 34588095
[TBL] [Abstract][Full Text] [Related]
38. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters.
Roberts A; Vogel L; Guarner J; Hayes N; Murphy B; Zaki S; Subbarao K
J Virol; 2005 Jan; 79(1):503-11. PubMed ID: 15596843
[TBL] [Abstract][Full Text] [Related]
39. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters.
Kinoshita T; Watanabe K; Sakurai Y; Nishi K; Yoshikawa R; Yasuda J
Sci Rep; 2021 Oct; 11(1):21259. PubMed ID: 34711897
[TBL] [Abstract][Full Text] [Related]
40. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
Carroll T; Fox D; van Doremalen N; Ball E; Morris MK; Sotomayor-Gonzalez A; Servellita V; Rustagi A; Yinda CK; Fritts L; Port JR; Ma ZM; Holbrook MG; Schulz J; Blish CA; Hanson C; Chiu CY; Munster V; Stanley S; Miller CJ
PLoS Pathog; 2022 Feb; 18(2):e1009914. PubMed ID: 35143587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
